Terms: = Thyroid cancer AND ATR, Q13535, 545, ENSG00000175054, MEC1, SCKL, SCKL1, FRP1 AND Prognosis
15 results:
1. [Efficacy and safety of Anlotinib in the treatment of advanced sarcoma].
Yan Q; Yao WT; Du XH; Guo LY; Fan YC
Zhonghua Zhong Liu Za Zhi; 2023 Oct; 45(10):904-910. PubMed ID: 37875427
[No Abstract] [Full Text] [Related]
2. Impact of adjuvant chemotherapy on T1N0M0 breast cancer patients: a propensity score matching study based on SEER database and external cohort.
Shen K; Yao L; Zhu J; Gu X; Wang J; Qian W; Zheng Z; Fu D; Wu S
BMC Cancer; 2022 Aug; 22(1):863. PubMed ID: 35941565
[TBL] [Abstract] [Full Text] [Related]
3. Prognostic Value of Combined Lactate Dehydrogenase, C-Reactive Protein, cancer Antigen 153 and cancer Antigen 125 in Metastatic Breast cancer.
Ma YY; Wang H; Zhao WD; Li YF; Wang JJ; Chen XY; Huang YQ; Wang WJ; Wang Y; Sun SC
Cancer Control; 2022; 29():10732748211053150. PubMed ID: 34989251
[TBL] [Abstract] [Full Text] [Related]
4. LncRNA OTUD6B-AS1 promotes paclitaxel resistance in triple negative breast cancer by regulation of miR-26a-5p/MTDH pathway-mediated autophagy and genomic instability.
Li PP; Li RG; Huang YQ; Lu JP; Zhang WJ; Wang ZY
Aging (Albany NY); 2021 Nov; 13(21):24171-24191. PubMed ID: 34740994
[TBL] [Abstract] [Full Text] [Related]
5. A 6 transcription factors-associated nomogram predicts the recurrence-free survival of thyroid papillary carcinoma.
Wang T; Tian K; Ji X; Song F
Medicine (Baltimore); 2021 Oct; 100(40):e27308. PubMed ID: 34622829
[TBL] [Abstract] [Full Text] [Related]
6. atr-FTIR spectroscopy and CDKN1C gene expression in the prediction of lymph nodes metastases in papillary thyroid carcinoma.
da Silva RM; Pupin B; Bhattacharjee TT; Vamondes Kulcsar MA; Uno M; Chammas R; de Azevedo Canevari R
Spectrochim Acta A Mol Biomol Spectrosc; 2020 Mar; 228():117693. PubMed ID: 31708464
[TBL] [Abstract] [Full Text] [Related]
7. The Prognostic Values of Preoperative Tumor Volume and Tumor Diameter in T1N0 Papillary thyroid cancer.
Lim ST; Jeon YW; Suh YJ
Cancer Res Treat; 2017 Oct; 49(4):890-897. PubMed ID: 28052656
[TBL] [Abstract] [Full Text] [Related]
8. Differential Clinicopathological Risk and prognosis of Major Papillary thyroid cancer Variants.
Shi X; Liu R; Basolo F; Giannini R; Shen X; Teng D; Guan H; Shan Z; Teng W; Musholt TJ; Al-Kuraya K; Fugazzola L; Colombo C; Kebebew E; Jarzab B; Czarniecka A; Bendlova B; Sykorova V; Sobrinho-Simões M; Soares P; Shong YK; Kim TY; Cheng S; Asa SL; Viola D; Elisei R; Yip L; Mian C; Vianello F; Wang Y; Zhao S; Oler G; Cerutti JM; Puxeddu E; Qu S; Wei Q; Xu H; O'Neill CJ; Sywak MS; Clifton-Bligh R; Lam AK; Riesco-Eizaguirre G; Santisteban P; Yu H; Tallini G; Holt EH; Vasko V; Xing M
J Clin Endocrinol Metab; 2016 Jan; 101(1):264-74. PubMed ID: 26529630
[TBL] [Abstract] [Full Text] [Related]
9. Nuclear C-MYC expression level is associated with disease progression and potentially predictive of two year overall survival in prostate cancer.
Zeng W; Sun H; Meng F; Liu Z; Xiong J; Zhou S; Li F; Hu J; Hu Z; Liu Z
Int J Clin Exp Pathol; 2015; 8(2):1878-88. PubMed ID: 25973080
[TBL] [Abstract] [Full Text] [Related]
10. Does papillary thyroid carcinoma have a better prognosis with or without Hashimoto thyroiditis?
Kwak HY; Chae BJ; Eom YH; Hong YR; Seo JB; Lee SH; Song BJ; Jung SS; Bae JS
Int J Clin Oncol; 2015 Jun; 20(3):463-73. PubMed ID: 25312294
[TBL] [Abstract] [Full Text] [Related]
11. Does preoperative neutrophil lymphocyte ratio predict risk of recurrence and occult central nodal metastasis in papillary thyroid carcinoma?
Lang BH; Ng CP; Au KB; Wong KP; Wong KK; Wan KY
World J Surg; 2014 Oct; 38(10):2605-12. PubMed ID: 24809487
[TBL] [Abstract] [Full Text] [Related]
12. Excellent prognosis of patients with solitary T1N0M0 papillary thyroid carcinoma who underwent thyroidectomy and elective lymph node dissection without radioiodine therapy.
Ito Y; Masuoka H; Fukushima M; Inoue H; Kihara M; Tomoda C; Higashiyama T; Takamura Y; Kobayashi K; Miya A; Miyauchi A
World J Surg; 2010 Jun; 34(6):1285-90. PubMed ID: 20041244
[TBL] [Abstract] [Full Text] [Related]
13. Survival analysis of 19 patients with toxic thyroid carcinoma.
Als C; Gedeon P; Rösler H; Minder C; Netzer P; Laissue JA
J Clin Endocrinol Metab; 2002 Sep; 87(9):4122-7. PubMed ID: 12213859
[TBL] [Abstract] [Full Text] [Related]
14. Expression of p21 ras protein as a prognostic factor in papillary thyroid cancer.
Basolo F; Pinchera A; Fugazzola L; Fontanini G; Elisei R; Romei C; Pacini F
Eur J Cancer; 1994; 30A(2):171-4. PubMed ID: 7908818
[TBL] [Abstract] [Full Text] [Related]
15. Factors affecting the prognosis of patients with carcinoma of the thyroid.
Ito J; Noguchi S; Murakami N; Noguchi A
Surg Gynecol Obstet; 1980 Apr; 150(4):539-44. PubMed ID: 7361243
[TBL] [Abstract] [Full Text] [Related]
